Cloned (Comment) | Organism |
---|---|
gene SULT2A1, recombinant expression | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4'-hydroxytoremifene | - |
Homo sapiens | |
4-hydroxytoremifene | - |
Homo sapiens | |
7-methoxylasofoxifene | - |
Homo sapiens | |
acolbifene | - |
Homo sapiens | |
arzoxifene | full mixed inhibition | Homo sapiens | |
bazedoxifene | full noncompetitive inhibition | Homo sapiens | |
bazedoxifene N-oxide | - |
Homo sapiens | |
cis-4-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthalenyl)phenol | - |
Homo sapiens | |
clomifene | full competitive inhibition | Homo sapiens | |
des(1-azepanyl)ethylbazedoxifene | - |
Homo sapiens | |
droloxifene | partial mixed inhibition | Homo sapiens | |
glycolithocholic acid | substrate inhibition | Homo sapiens | |
lasofoxifene | full noncompetitive inhibition | Homo sapiens | |
lithocholic acid | substrate inhibition | Homo sapiens | |
additional information | inhibition of human sulfotransferase 2A1-catalyzed sulfonation of lithocholic acid (LCA), glycolithocholic acid (GLCA), and taurolithocholic acid (TLCA) by selective estrogen receptor modulators and various analogs and metabolites. The triphenylethylene, benzothiophene, tetrahydronaphthalene, indole, and and benzopyran classes of selective estrogen receptor modulator (SERM) inhibit LCA, GLCA, and TLCA sulfonation, mode of inhibition, and MIC values, overview. Bazedoxifene and raloxifene are the most effective inhibitors of LCA, GLCA, and TLCA sulfonation, while tamoxifen is the least potent inhibitor. No inhibition by amoxicillin. The order of inhibition of LCA sulfonation by toremifene and its oxidative metabolites is N-desmethyl-4-hydroxytoremifene > 4-hydroxytoremifene > toremifene > N-desmethyltoremifene | Homo sapiens | |
N-desmethyl-4-hydroxytoremifene | - |
Homo sapiens | |
N-desmethyltoremifene | - |
Homo sapiens | |
nafoxidine | - |
Homo sapiens | |
ospemifene | - |
Homo sapiens | |
raloxifene | raloxifene is linked to the development of cholestasis, and it inhibits sulfotransferase 2A1 (SULT2A1)-catalyzed dehydroepiandrosterone (DHEA) sulfonation, full noncompetitive inhibition | Homo sapiens | |
tamoxifen | tamoxifen is linked to the development of cholestasis, and it inhibits sulfotransferase 2A1 (SULT2A1)-catalyzed dehydroepiandrosterone (DHEA) sulfonation | Homo sapiens | |
taurolithocholic acid | substrate inhibition | Homo sapiens | |
toremifene | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00034 | - |
lithocholic acid | recombinant SULT2A1, pH 7.4, 37°C | Homo sapiens | |
0.0004 | - |
taurolithocholic acid | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.00048 | - |
glycolithocholic acid | recombinant SULT2A1, pH 7.4, 37°C | Homo sapiens | |
0.00099 | - |
glycolithocholic acid | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.0011 | - |
lithocholic acid | liver cytosol, pH 7.4, 37°C | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
3'-phosphoadenylyl sulfate + dehydroepiandrosterone | Homo sapiens | - |
adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + glycolithocholic acid | Homo sapiens | - |
adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + lithocholic acid | Homo sapiens | - |
adenosine 3',5'-bisphosphate + lithocholate 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + taurolithocholic acid | Homo sapiens | - |
adenosine 3',5'-bisphosphate + taurolithocholate 3-sulfate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q06520 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
Hep-G2 cell | - |
Homo sapiens | - |
hepatoma cell | - |
Homo sapiens | - |
liver | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
3'-phosphoadenylyl sulfate + (S)-dehydroepiandrosterone | - |
Homo sapiens | adenosine 3',5'-bisphosphate + (S)-dehydroepiandrosterone 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + dehydroepiandrosterone | - |
Homo sapiens | adenosine 3',5'-bisphosphate + dehydroepiandrosterone 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + glycolithocholic acid | - |
Homo sapiens | adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + lithocholic acid | - |
Homo sapiens | adenosine 3',5'-bisphosphate + lithocholate 3-sulfate | - |
? | |
3'-phosphoadenylyl sulfate + taurolithocholic acid | - |
Homo sapiens | adenosine 3',5'-bisphosphate + taurolithocholate 3-sulfate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
More | see also EC 2.8.2.14 | Homo sapiens |
sulfotransferase 2A1 | - |
Homo sapiens |
SULT2A1 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | inhibition kinetics and modeling, detailed overview | Homo sapiens | |
0.0002 | - |
bazedoxifene | liver cytosol, pH 7.4, 37°C, substrate lithocholic acid, noncompetitive inhibition | Homo sapiens | |
0.0005 | - |
raloxifene | liver cytosol, pH 7.4, 37°C, substrate lithocholic acid, noncompetitive inhibition | Homo sapiens | |
0.0008 | - |
arzoxifene | liver cytosol, pH 7.4, 37°C, substrate lithocholic acid, mixed inhibition | Homo sapiens | |
0.0008 | - |
lasofoxifene | liver cytosol, pH 7.4, 37°C, substrate lithocholic acid, noncompetitive inhibition | Homo sapiens | |
0.0046 | - |
droloxifene | liver cytosol, pH 7.4, 37°C, substrate lithocholic acid, mixed inhibition | Homo sapiens | |
0.0057 | - |
lithocholic acid | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.0058 | - |
clomifene | liver cytosol, pH 7.4, 37°C, substrate lithocholic acid, competitive inhibition | Homo sapiens | |
0.0081 | - |
taurolithocholic acid | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.0096 | - |
glycolithocholic acid | recombinant SULT2A1, pH 7.4, 37°C | Homo sapiens | |
0.0123 | - |
glycolithocholic acid | liver cytosol, pH 7.4, 37°C | Homo sapiens | |
0.0391 | - |
lithocholic acid | recombinant SULT2A1, pH 7.4, 37°C | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00006 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | bazedoxifene N-oxide | |
0.00008 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | arzoxifene | |
0.00013 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | bazedoxifene | |
0.00016 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | des(1-azepanyl)ethylbazedoxifene | |
0.00018 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | raloxifene | |
0.0002 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | arzoxifene | |
0.00021 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | bazedoxifene | |
0.00025 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | lasofoxifene | |
0.00028 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | raloxifene | |
0.00029 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | bazedoxifene | |
0.00029 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | arzoxifene | |
0.00041 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | raloxifene | |
0.0005 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | lasofoxifene | |
0.00075 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | droloxifene | |
0.001 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | lasofoxifene | |
0.0014 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | cis-4-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthalenyl)phenol | |
0.0014 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | nafoxidine | |
0.0015 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | droloxifene | |
0.0015 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | droloxifene | |
0.0015 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | clomifene | |
0.0018 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | 4'-hydroxytoremifene | |
0.0023 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | ospemifene | |
0.00255 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | ospemifene | |
0.0029 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | 7-methoxylasofoxifene | |
0.003 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | ospemifene | |
0.0032 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | clomifene | |
0.0032 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | toremifene | |
0.0036 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | clomifene | |
0.0044 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | 4-hydroxytoremifene | |
0.0066 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | nafoxidine | |
0.007 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | acolbifene | |
0.0092 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | toremifene | |
0.0101 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | acolbifene | |
0.0101 | - |
liver cytosol, pH 7.4, 37°C, substrate taurolithocholic acid | Homo sapiens | tamoxifen | |
0.011 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | toremifene | |
0.0122 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | nafoxidine | |
0.0129 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | acolbifene | |
0.0129 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | N-desmethyl-4-hydroxytoremifene | |
0.0137 | - |
liver cytosol, pH 7.4, 37°C, substrate glycolithocholic acid | Homo sapiens | tamoxifen | |
0.0163 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | tamoxifen | |
0.0184 | - |
liver cytosol, pH 7.4, 37°C, substrate lithocholic acid | Homo sapiens | N-desmethyltoremifene |
General Information | Comment | Organism |
---|---|---|
malfunction | tamoxifen or raloxifene are linked to the development of cholestasis, and inhibit sulfotransferase 2A1 (SULT2A1)-catalyzed dehydroepiandrosterone (DHEA) sulfonation | Homo sapiens |